Thursday, March 23, 2023 | Back issues
Courthouse News Service Courthouse News Service

Birth Defects

OAKLAND, Calif. - GlaxoSmithKline pushed its drug Zofran, approved to fight side effects of chemotherapy, for off-label treatment of morning sickness, and a woman's baby was born with "devastating" heart defects because of it, she claims in Alameda County Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.